Transforming HIV diagnosis: A low-cost, point-of-care detection solution
A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...
emjreviews.com1h
Twice-Yearly HIV Prevention Shot Nears FDA Decision
The FDA has accepted a priority review of a new biannual HIV prevention injection, with a decision expected by June 19, 2025.
New paper-based device boosts HIV test accuracy from dried blood samples
In parts of the world where traveling to a clinic for routine blood tests is a financial and logistical challenge, HIV ...
Monthly Prescribing Reference18h
Twice-Yearly Lenacapavir Gets Priority Review For HIV PrEP
The Food and Drug Administration (FDA) has accepted under Priority Review the New Drug Application (NDA) for lenacapavir, a long-acting HIV-1 capsid inhibitor, for the prevention of HIV as ...
How Trump’s policies could reverse decades of progress in Latin America’s HIV response
It was nearly 30 years ago when Rosember Lopez received a life-altering diagnosis: He was HIV positive. With scant government ...
unaids20h
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them
In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...
Canada6d
HIV and AIDS: Symptoms and treatment
Some people may not develop any symptoms after contracting HIV and could remain undiagnosed until the symptoms of AIDS appear. This could be up to 10 years later. However, 50% or more of people living ...